What is Transchem Ltd (TRANSCHEM) share price return in the past 10 years?

Transchem Ltd share price has appreciated 32.1% annually (CAGR) over the past ten years.

What is the share price of Transchem Ltd (TRANSCHEM)?

Company share prices are keep on changing according to the market conditions. The current trading price of Transchem Ltd (TRANSCHEM) on 05-Jun-2026 16:59:59 at 16:59 is 285.90.

What is the P/E ratio of Transchem?

The latest standalone P/E ratio of Transchem as of 05-Jun-2026 is 77.58.

What is the P/B ratio of Transchem Ltd (TRANSCHEM)?

The latest standalone P/B ratio of Transchem Ltd (TRANSCHEM) as of 05-Jun-2026 is 3.99.

What is the 52-week high and low of Transchem Ltd (TRANSCHEM)?

The 52-week high of Transchem Ltd (TRANSCHEM) is Rs. 285.90 and the 52-week low is Rs. 37.00.

Transchem Ltd (TRANSCHEM) Share Analysis – Quality, Valuation Zone & Price Trend & DeciZen Rating

Name: Transchem Ltd (TRANSCHEM)
Brand: Transchem

Transchem Ltd (TRANSCHEM)

Share Analysis – Quality, Valuation Zone, Price Trend & DeciZen Rating BSE: 500422 NSE: TRANSCHEM Trading | Small Cap | Transchem Share Price

Transchem Ltd (TRANSCHEM)

Share Analysis – Quality, Valuation Zone, Price Trend & DeciZen Rating BSE: 500422 NSE: TRANSCHEM Trading | Small Cap | Transchem Share Price

Key Metrics

Valuation Multiples

Market Cap

₹333 Cr.

Current Price

₹285.9

52-Week Low / High

₹37 / 286

TTM EPS

₹3.5

TTM Sales

₹0 Cr.

Book Value per Share

₹68.3

P/E Ratio

77.58

Higher than its 5-year historical median

Industry PE

Price to Book (P/B)

3.99

Higher than its 5-year historical median

Price to Sales (P/S)

0.00

Lower than its 3-year historical median

EV/EBITDA

51.77

Higher than its 5-year historical median

Dividend Yield

0.00%

Profitability Efficiency

Return on Equity (ROE)

6.74%

Outperforms industry median

Return on Capital Employed (ROCE)

9.12%

Outperforms industry median

Return on Assets (ROA)

6.70%

Operating Profit Margin

-55.7%

Net Profit Margin

198.67%

Gross Profit Margin

268.7%

Growth Momentum
1-yr vs 3-yr growth

Sales Growth (1 Year)

541.46%

Operating Profit Growth (1 Year)

Net Profit Growth (1 Year)

Improving versus 3-year growth rate

24.52%

Asset Quality

Promoter Holding

56.45%

Pledged shares (%) of Promoter's holding (%)

0.00%

Reserves

₹71 Cr.

Equity

₹12.2 Cr.

Face Value

₹10

All Time Low / High

₹2.55 / 272.30

Transchem stock performance

Key Ratios

Check Before You Invest

Quality

Not Good

Check detailed performance

Valuation

Overvalued

Check Valuation charts

Price Trend

Weak

Check Price chart

Q.1 Is Transchem Ltd a good quality company?

Transchem Ltd is a weak quality company, based on a inconsistent multi-year financial track record.

This assessment is based on company’s performance on Revenue growth, ROCE, Equity and Assets, key margin ratios, cash conversion cycle, and debt to cash flow from operations and how it compares with its long term averages.

We have analysed the performance of the company on the following:

How has it performed on generating Profits?
By checking its Revenue growth, Gross, Operating and Net Margins compared to its last 5-year median.
How efficiently has it utilized Capital?
By checking its ROCE, ROA, ROE and its Cash Conversion Cycle.
How is it managing its Debt?
By checking its Debt to Equity and Cash Flow from Operations.

How does Transchem Ltd performance compare with that of its Peers?

Q.1 Revenue growth of Transchem Ltd vs industry peers?

Transchem Ltd revenue CAGR is 0.00%, compared to the industry median CAGR of 4.99%, indicating slower growth and losing its market share.

Q.1 Promoter shareholding and pledge status of Transchem Ltd?

Promoters hold 56.45% of the Transchem Ltd, with 0.00% of their stake pledged, indicating no pledge risk.

Q.1 Stock return of Transchem Ltd over the last decade?

Over the last 9 year(s), the stock has delivered a CAGR of 25.9% based on the current price.

10 Year X-Ray :

Analysis of Financial Track Record (Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end)

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end

Value Creation ⓘ

	Mar'16	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23	Mar'24	Mar'25	TTM
ROCE % ⓘ	0.1%	-0.6%	-1.5%	2.1%	2.1%	49.7%	6.1%	3.8%	8%	9.1%	-
Value Creation Index ⓘ	-1.0	-1.0	-1.1	-0.9	-0.9	2.6	-0.6	-0.7	-0.4	-0.4	-
Growth Parameters ⓘ
Sales ⓘ	0	0	0	0	0	22.5	0	0	0.4	2.6	0
Sales YoY Gr.	-	NA	NA	NA	NA	NA	-100%	NA	NA	541.5%	-
Adj EPS ⓘ	-0.9	-1.1	-1.5	0.1	0.3	19.7	2.3	1	3.4	4	3.5
YoY Gr.	-	NA	NA	NA	135.7%	5878.8%	-88.1%	-56.8%	239.6%	16.3%	-
BVPS (₹) ⓘ	31.4	31	30.1	31	30	51.4	54.2	53.8	61.8	64.8	68.3
Adj Net Profit ⓘ	-1.1	-1.3	-1.8	0.2	0.4	24.2	2.9	1.2	4.2	4.9	4
Cash Flow from Ops. ⓘ	1.1	0.6	-19.8	10.3	-0.6	-27.7	21.9	1.2	-39.3	36	-
Debt/CF from Ops. ⓘ	0	0	0	0	0	0	0	0	0	0	-

CAGR ⓘ

	9 Years	5 Years	3 Years	1 Years
Sales ⓘ	NA	NA	NA	541.5%
Adj EPS ⓘ	NA	64.6%	19.5%	16.3%
BVPSⓘ	8.4%	16.6%	6.2%	4.9%
Share Price	32.1%	60.1%	140.5%	618%

Key Financial Parameters ⓘ

	Mar'16	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23	Mar'24	Mar'25	TTM
Return on Equity % ⓘ	-2.9	-3.4	-4.9	0.4	1.1	48.5	4.4	1.9	5.9	6.3	5.3
Op. Profit Mgn % ⓘ	0	0	0	0	0	91.4	0	0	-423.4	-55.7	NAN
Net Profit Mgn % ⓘ	0	0	0	0	0	107.5	0	0	1025.2	185.5	INF
Debt to Equity ⓘ	0	0	0	0	0	0	0	0	0	0	0
Working Cap Days ⓘ	0	0	0	0	0	457	0	0	40,246	7,099	0
Cash Conv. Cycle ⓘ	0	0	0	0	0	1	0	0	183	209	0

Profit And Loss

(All Figures are in Crores.)

PARTICULARS	Mar'16	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23	Mar'24	Mar'25
Sales	0	0	0	0	0	22	0	0	0	3
Operating Expenses ⓘ +	1	1	2	1	1	2	3	2	2	4
Manufacturing Costs	0	0	0	0	0	0	0	0	0	0
Material Costs	0	0	0	0	0	0	0	0	0	3
Employee Cost	0	0	0	0	1	1	1	1	1	1
Other Costs ⓘ	1	1	1	1	1	1	2	1	1	1
Operating Profit ⓘ	-1	-1	-2	-1	-1	21	-3	-2	-2	-1
Operating Profit Margin (%)	-	-	-	-	-	91.4%	-	-	-423.0%	-55.7%
Other Income ⓘ +	2	2	2	3	3	4	7	4	7	9
Exceptional Items ⓘ	0	0	0	0	0	0	0	0	0	0
Interest ⓘ	0	0	0	0	0	0	0	0	0	0
Depreciation ⓘ	1	1	1	1	1	0	0	0	0	0
Profit Before Tax ⓘ	0	-0	-1	1	1	25	4	3	6	7
Tax ⓘ	0	0	1	0	0	1	1	1	1	2
Profit After Tax	0	-0	-1	0	0	24	3	1	4	5
PAT Margin (%)	-	-	-	-	-	107.5%	-	-	1,025.2%	198.7%
Adjusted EPS (₹)	0.0	-0.2	-1.0	0.3	0.3	19.7	2.3	1.0	3.4	4.3
Dividend Payout Ratio (%)	0%	0%	0%	0%	0%	0%	0%	0%	0%	0%

Valuation of Transchem - Standalone

YTD 1Y 3Y 5Y 10Y Max

Analyst's Notes

No data found!

Balance Sheet

(All Figures are in Crores.)

PARTICULARS	Mar'16	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23	Mar'24	Mar'25
Equity and Liabilities
Shareholders Fund +	38	38	37	38	37	63	66	66	76	79
Share Capital ⓘ	12	12	12	12	12	12	12	12	12	12
Reserves ⓘ	26	26	25	26	25	51	54	54	63	67
Debt +	0	0	0	0	0	0	0	0	0	0
Long Term Debt	0	0	0	0	0	0	0	0	0	0
Short Term Debt	0	0	0	0	0	0	0	0	0	0
Minority Interest	0	0	0	0	0	0	0	0	0	0
Trade Payables	0	0	0	0	0	0	0	0	0	0
Others Liabilities ⓘ	-0	-0	0	0	0	0	1	0	1	0
Total Liabilities ⓘ	38	38	37	38	37	63	67	66	76	80
Fixed Assets
Net Fixed Assets ⓘ +	7	6	5	4	4	0	0	0	0	0
Gross Block	38	7	7	6	6	0	0	0	0	0
Accumulated Depreciation	30	1	2	2	2	0	0	0	0	0
CWIP ⓘ	0	0	0	0	0	0	0	0	0	0
Investments ⓘ	28	30	10	6	4	9	9	8	9	2
Inventories	1	1	0	0	0	0	0	0	0	0
Trade Receivables	0	0	0	0	0	0	0	0	0	3
Cash Equivalents ⓘ	1	0	0	16	16	12	34	34	0	42
Others Assets ⓘ	0	0	21	12	13	43	24	23	67	33
Total Assets ⓘ	38	38	37	38	37	63	67	66	76	80

Cash Flow

(All Figures are in Crores.)

PARTICULARS	Mar'16	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23	Mar'24	Mar'25
Cash Flow From Operating Activity ⓘ +	1	1	-20	10	-1	-28	22	1	-39	36
PBT ⓘ	0	-0	-1	1	1	25	4	3	6	7
Adjustment ⓘ	1	1	1	1	1	-22	-0	-0	-0	-1
Changes in Working Capital ⓘ	0	-0	-21	9	-1	-29	19	-0	-44	32
Tax Paid ⓘ	0	0	-0	-0	-1	-1	-1	-1	-1	-2
Cash Flow From Investing Activity ⓘ +	-0	-2	20	6	1	23	1	-1	5	6
Capex	-0	-0	0	0	0	26	0	0	-0	1
Net Investments	-1	-2	20	5	1	-3	1	-1	5	5
Others ⓘ	0	0	0	0	0	0	0	0	0	0
Cash Flow From Financing Activity ⓘ +	0	0	0	0	0	0	0	0	0	0
Net Proceeds from Shares ⓘ	0	0	0	0	0	0	0	0	0	0
Net Proceeds from Borrowing ⓘ	0	0	0	0	0	0	0	0	0	0
Interest Paid ⓘ	0	0	0	0	0	0	0	0	0	0
Dividend Paid ⓘ	0	0	0	0	0	0	0	0	0	0
Others ⓘ	0	0	0	0	0	0	0	0	0	0
Net Cash Flow ⓘ	1	-1	-0	16	0	-5	23	0	-34	42

Financial Ratio

PARTICULARS	Mar'16	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23	Mar'24	Mar'25
Ratios
ROE (%)	0.12	-0.57	-3.18	0.82	1.1	48.44	4.44	1.87	5.94	6.74
ROCE (%)	0.12	-0.57	-1.47	2.07	2.12	49.69	6.05	3.79	7.99	9.12
Asset Turnover Ratio	0	0	0	0	0	0.45	0	0	0.01	0.03
PAT to CFO Conversion(x)	N/A	N/A	N/A	N/A	N/A	-1.17	7.33	1	-9.75	7.2
Working Capital Days
Receivable Days	0	0	0	0	0	0	0	0	365	216.40
Inventory Days	0	0	0	0	0	1.20	0	0	0	0
Payable Days	0	0	0	0	0	0	0	0	0	19.10

Management X-Ray

Shareholding Pattern

Promoter's Holding & Share Pledging

Pledged ^*

0.00

* Pledged shares as % of Promoter's holding (%)

Top 5 Mutual Funds Holding

Last Visited Stocks

Announcements

Transchem Ltd FAQs

The current trading price of Transchem on 05-Jun-2026 16:59 is ₹285.9.

Market capitalization or market cap is determined by multiplying the current market price of a company's shares with the total number of shares outstanding. As of 04-Jun-2026 the market cap of Transchem stood at ₹333.3 Cr

The latest P/E ratio of Transchem as of 04-Jun-2026 is 77.58.

The latest P/B ratio of Transchem as of 04-Jun-2026 is 3.99.

The 52-week high of Transchem is ₹285.9 and the 52-week low is ₹37.00.

The TTM revenue is Trailing Twelve Months sales. The TTM revenue/sales of Transchem is ₹0.00 ( Cr.) .

Past 10 year’s financial track record analysis by Moneyworks4me indicates that Transchem Ltd is a below average quality company.

The key valuation ratios of Transchem Ltd's currently when compared to its past seem to suggest it is in the Overvalued zone.

The Price Trend analysis by MoneyWorks4Me indicates it is Weak which suggest that the price of Transchem Ltd is likely to Fall in the short term. However, please check the rating on Quality and Valuation before investing.

About Transchem Ltd

Transchem limited is a professionally managed, public limited company, the API manufacturing operations were started in 1993. The company is reputed as quality conscious manufacturer and exporter of specialized high quality API's and pharmaceutical intermediates.

The company is the largest producer of widest range of Anathematic API's (Anti-Parasitic) in the world, manufactured under one roof in WHO GMP accredited facility. It also offers specialized range of human use APIâ€™s.

The company is having four state of the art GMP approved facilities at multiple locations in India, with total production capacity of 500 MT per annum.

The company is one of the largest suppliers of Albendazole, Clorsulon, Diminazene Diaceturate, Toldimfos Sodium, Oxfendazole, Fenbendazole, Flubendazole, Mebendazole, Nitroxynil, Ramipril from India and can meet all the requiered technical and quality aspects of esteemed organizations and is now focusing on Anti-Hypertensive and Anti-Diabetic range of products.

Products and services offered by the company:

Services:

Contract Research Facility.
Custom Synthesis of Molecules.
Contract Manufacturing of API's as per GMP Guidelines.
Intermediates.
Veterinary Formulations.
Q.A. & Regulatory Support.

Product:

Anthelmintics

Albendazole USP / EP /BP
Ricobendazole (Albendazole Sulphoxide)
Mebendazole EP / BP / USP / POLY 'C'
Oxyclozanide BP VET
Closantel Sodium EP / BASE
Clorsulon USP
Nitroscanate
Fenbendazole EP/BP/BP VET
Oxfendazole BP VET / EP
Flubendazole EP / 98%
Nitroxynil BP VET
Rafoxanide BP VET
Triclabendazole
Praziquantel BP / USP

Veterinary API's

Diminazene Diaceturate B VET C
Quinapyramine Salts B VET C
Parvaquone
Toldimfos Sodium
Acepromazine Maleate BP VET
Butaphosphan
Flunixin Meglumine USP
Homidium Bromide / Chloride
Isometamedium

Ectoparaciticides

Cyromazine.
Cymiazole
S-Methoprene
Azamethiphos.

Human Use API's

Ramipril EP
Frusemide EP / BP / USP
Gabapentin USP
Cetirizine DI HCL EP/BP
Lamotrigine
Pentamidine Isetionate BP
Succinylcholine Chloride USP
Epinastine HCL
Nifuroxazide

Transchem Ltd (TRANSCHEM)

Transchem Ltd (TRANSCHEM)

Transchem stock performance